Fundraising FoxModality
4 known investors
Find your way into Modality
1,003 people in our graph can introduce you to the Modality team.
Sign up to see every warm intro you have to Modality
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Modality team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Modality.AI develops an AI-based multimodal assessment platform that uses app-collected data to help diagnose and monitor neurodegenerative diseases such as ALS. It serves clinicians and patients, aiming to reduce reliance on in-clinic evaluations for conditions like ALS.
Founders & leadership
DP
David PautlerCo-founder & CTOHe has background in computational cognitive modeling and software development with expertise in natural language processing and non-verbal behavior analysis.
Investors · 4
Related companies · 6
VisoViso.ai offers a computer vision platform with two products: Visonow, a tool to build vision agents from a text prompt and video, and Visosuite, an enterprise operating system to connect cameras across sites and run governed, agentic vision workflows at scale. It serves enterprises across multiple industries for use cases like monitoring, inspection, and safety alerting.
Definitive HealthcareDefinitive Healthcare delivers market intelligence and data analytics on healthcare organizations, clinicians, and consumers, serving life sciences companies, healthcare providers, and other industries that interact with healthcare. The company provides data consolidation, analytics services, and digital advertising activation capabilities to help customers make informed decisions in the healthcare market.
ModalModal provides a cloud platform that lets developers define compute, hardware, and application logic in Python and deploy to the cloud, with fast-booting containers and autoscaling GPUs. It targets AI and ML workloads such as inference, model training, and large-scale parallel processing.
ItnonlineImaging Technology News is a trade publication that reaches over 34,000 radiology, radiation oncology, women's health, and nuclear medicine professionals with editorial content and product comparison tools. The publication serves as a primary resource for healthcare technology purchasing decisions within medical imaging specialties.
Massive BioMassive Bio operates an AI-based platform that matches cancer patients with oncology clinical trials and provides concierge support throughout the trial process. It serves patients across the U.S., Canada, Latin America, and Europe, and works with pharma and CRO customers, patient advocacy organizations, and the National Cancer Institute's network of cancer centers.
DiabetomicsModalityDx develops quantitative point-of-care diagnostic tests using molecular biomarkers and data science to detect and assess treatment response for diseases including diabetes, maternal health conditions, and autoimmune disorders. The company also supports pharmaceutical firms in drug development and therapeutic efficacy assessment.
Companies working in the same space as Modality.
Frequently asked questions
- What does Modality do?
- Modality.AI develops an AI-based multimodal assessment platform that uses app-collected data to help diagnose and monitor neurodegenerative diseases such as ALS. It serves clinicians and patients, aiming to reduce reliance on in-clinic evaluations for conditions like ALS.
- Who founded Modality?
- Modality was founded by David Suendermann-Oeft, David Pautler.
- Who are Modality's investors?
- Modality's investors include CARELA Holding GmbH, Device of Tomorrow Capital, Lair East Labs, Novalis Biotech.